GSK

How is GSK doing right now?

In plain terms: GSK is 13.8% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

GSK (GSK plc) is 13.8% below its historical peak. Tape reads in a moderate correction, with the last trade at $1,958. A drawdown of this depth is where patient buyers start paying attention. Historically the asymmetry begins to favor accumulation here, especially when paired with structural demand.

What history says at this drawdown

Across all available history, GSK has spent enough trading days in the 15%-to-10% drawdown band to build a large sample (493 observations). Dipsern segments these by drawdown depth and computes the rolling median forward 90-day return — that median is the primary signal you see in the full app, and it's substantially more robust than mean-based forecasts because it ignores fat-tail outliers in both directions.

What this means for GSK

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to GSK's own volatility history. Moderate corrections are the highest-information zone for the Dipsern signal: enough drawdown for mean-reversion to matter, not so much that fundamentals are likely broken. Watch the prediction-error column — if past signals at this level were accurate, the current one is more trustworthy.